*MedStar Georgetown University Hospital, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Washington, DC;
†Yale Child Study Center, Yale University School of Medicine, New Haven, CT;
‡University of Connecticut School of Nursing, Storrs, CT;
¦Yale School of Nursing, New Haven, CT; and
§Department of Population Health & Leadership, University of New Haven, New Haven, CT.
Address for reprints: Amalia Londoño Tobón, MD, MedStar Georgetown University Hospital, 2115 Wisconsin Avenue, NW, Suite #200 Washington, DC 20007; e-mail: [email protected].
This work was supported by the American Academy of Child and Adolescent Psychiatry Pilot Research Award, National Institute of Mental Health (NIMH T32 MH018268-34 and T32 MH019927), and Research Colloquium for Junior Investigators funded by the National Institute on Drug Abuse [NIDA: R13 DA042568-03] awarded to A.L.T., and by the NAPNAP Foundation, the Connecticut Nurses' Foundation, the Jonas Nurse Leaders Scholars Program, and the Alpha Nu Chapter of Sigma Theta Tau International, and the National Institute of Nursing Research of the National Institutes of Health (K99NR018876, F31NR016385, and T32NR008346) awarded to E.C.
Disclosure: The authors declare no conflict of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jdbp.org).
A.L.T. and E.C. contributed equally to this work.
